https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-18 / Genet Vaccines Ther 2008 Jan;6:2
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-18 / Genet Vaccines Ther 2008 Jan;6:22008-01-18 00:00:002019-02-15 09:24:02Therapeutic dendritic cell vaccine preparation using tumor RNA transfection: a promising approach for the treatment of prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-17 / Gene Ther. 2008 Mar;15(5):371-83
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-17 / Gene Ther. 2008 Mar;15(5):371-832008-01-17 00:00:002019-02-15 09:22:05Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-15 / Transfusion 2008 May;48(5):861-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-15 / Transfusion 2008 May;48(5):861-702008-01-15 00:00:002019-02-15 08:32:31Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-14 / Urol. Oncol. 2009 Jan-Feb;27(1):26-32
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-14 / Urol. Oncol. 2009 Jan-Feb;27(1):26-322008-01-14 00:00:002019-02-15 09:23:59Dendritic cells transduced with a PSMA-encoding adenovirus and cocultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against prostate cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-10 / J. Viral Hepat. 2008 Mar;15(3):219-28
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-10 / J. Viral Hepat. 2008 Mar;15(3):219-282008-01-10 00:00:002019-02-15 08:37:35Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / Methods Mol. Biol. 2008;423:139-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / Methods Mol. Biol. 2008;423:139-532008-01-01 00:00:002019-02-15 08:48:15Delivery of whole tumor lysate into dendritic cells for cancer vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / Cancer Ther 2008;6(B):955-964
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / Cancer Ther 2008;6(B):955-9642008-01-01 00:00:002019-02-15 08:52:42A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / Rev Recent Clin Trials 2008 Jan;3(1):10-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / Rev Recent Clin Trials 2008 Jan;3(1):10-212008-01-01 00:00:002019-02-15 08:46:52Dendritic cell immunotherapy for malignant gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / Hepatogastroenterology 2008 Jan-Feb;55(81):155-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / Hepatogastroenterology 2008 Jan-Feb;55(81):155-92008-01-01 00:00:002019-02-15 09:03:01Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2008-01-01 / J. Immunother. 2008 Jan;31(1):101-12
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2008-01-01 / J. Immunother. 2008 Jan;31(1):101-122008-01-01 00:00:002019-02-15 09:19:36Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients
